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Abstract
Background: Protein exchange kinetics correlate with the level of chromatin condensation and, in many cases,
with the level of transcription. We used fluorescence recovery after photobleaching (FRAP) to analyse the kinetics
of 18 proteins and determine the relationships between nuclear arrangement, protein molecular weight, global
transcription level, and recovery kinetics. In particular, we studied heterochromatin-specific heterochromatin protein
1b (HP1b) B lymphoma Mo-MLV insertion region 1 (BMI1), and telomeric-repeat binding factor 1 (TRF1) proteins,
and nucleolus-related proteins, upstream binding factor (UBF) and RNA polymerase I large subunit (RPA194). We
considered whether the trajectories and kinetics of particular proteins change in response to histone
hyperacetylation by histone deacetylase (HDAC) inhibitors or after suppression of transcription by actinomycin D.
Results: We show that protein dynamics are influenced by many factors and events, including nuclear pattern and
transcription activity. A slower recovery after photobleaching was found when proteins, such as HP1b, BMI1, TRF1,
and others accumulated at specific foci. In identical cells, proteins that were evenly dispersed throughout the
nucleoplasm recovered more rapidly. Distinct trajectories for HP1b, BMI1, and TRF1 were observed after
hyperacetylation or suppression of transcription. The relationship between protein trajectory and transcription level
was confirmed for telomeric protein TRF1, but not for HP1b or BMI1 proteins. Moreover, heterogeneity of foci
movement was especially observed when we made distinctions between centrally and peripherally positioned foci.
Conclusion: Based on our results, we propose that protein kinetics are likely influenced by several factors,
including chromatin condensation, differentiation, local protein density, protein binding efficiency, and nuclear
pattern. These factors and events likely cooperate to dictate the mobility of particular proteins.
Background
The eukaryotic nucleus is highly compartmentalised.
The functional consequences of nuclear compartmenta-
lisation have been described previously in both fixed
and live cells [1-3]. Generally, chromatin consists of his-
tones wrapped with DNA and the many proteins that
are directly responsible for proper nuclear functions,
such as replication, transcription, splicing, and DNA
repair. Nuclear processes proceed in specific compart-
ments, such as nuclear foci, transcription and replication
factories, or nuclear speckles (summarised in [4,5]).
Moreover, interphase chromosomes are arranged into
chromosome territories, which can intermingle to some
degree [4,6,7]. Centromeres and telomeres are also
essential structures for chromosome function. Centro-
meres are the sites of mitotic spindle attachment and
are required for cell division [8]. Telomeres, which
include the shelterin proteins (telomeric-repeat binding
factor 1 (TRF1), TRF2, protection of telomeres 1
(POT1), tripeptidyl peptidase 1 (TPP1), Ras-related pro-
tein 1 (RAP1), and TRF1-interacting nuclear factor 2
(TIN2)), protect the ends of chromosomes and are
essential for chromosome stability [9,10]. Another pro-
minent nuclear structure is the nucleolus, which is the
largest transcription factory and is necessary for the
synthesis of ribosomal subunits [11-13]. Like the rest of
the genome, nucleoli are remarkably compartmentalised.
The nucleolar region consists of the fibrillar centre (FC),
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component (GC). The boundaries of nucleoli are sur-
rounded by clusters of centromeric heterochromatin,
called chromocentres [14]. The nucleolar organiser
regions (NORs) of specific acrocentric chromosomes are
responsible for the structural and functional properties
of nucleoli [15,16]. Many specific proteins preferentially
localise to the boundary between the FC and DFC,
which is thought to be the site of transcription of ribo-
somal genes. The transcription machinery used for
rRNA synthesis includes RNA polymerase I (RNA pol I)
and upstream binding factor (UBF) [17,18]. Gorski et al.
[19] measured the dynamic nature of these important
nucleolar proteins using fluorescence recovery after
photobleaching (FRAP). In that study, the fluorescence
recovery kinetics of several RNA pol I subunits in the
G1 and S phases of the cell cycle displayed biphasic
behaviour, characterised by fast fluorescence increase
f o l l o w e db yag e n t l ef l u o r e s cence recovery phase [19].
These authors also showed that the RNA polymerase I
recovery kinetics decrease as cell cycle-dependent tran-
scription increases. The transcription of RNA polymer-
a s eIc a nb es u p p r e s s e db ye x p o s u r et oav a r i e t yo f
stimuli. Actinomycin D is a widely used drug that inter-
calates into double stranded DNA and blocks the tran-
scription elongation activity of all three polymerases (I,
II, III) [20,21]. Therefore, actinomycin D is a useful
agent that enables the study of gene silencing and corre-
sponding epigenetic events.
Green fluorescent protein (GFP) technologies com-
bined with microscopy have opened a new avenue for
studying the mobility of tagged proteins in living cells.
However, most methods are limited by the confocal
optical resolution of about 200 nm laterally and 600 nm
axially [22]. Thus, several microscopy techniques have
been developed to improve the microscope resolution to
10 to 20 nm. The new methods include 4Pi microscopy
[23], localisation microscopy approaches [22], three-
dimensional structured illumination microscopy
(3D-SIM) [24], and stimulated emission depletion
microscopy (STED) [25]. Photobleaching methods are
used to analyse the kinetic properties of particular
proteins [1,26]. Many chromatin-related proteins have
been studied using the FRAP technique to measure local
protein dynamics, which are important functional char-
acteristics of these proteins. For example, two distinct
kinetic pools for Polycomb group-related protein, B lym-
phoma Mo-MLV insertion region 1 (BMI1), have been
described [27]. Similarly, Wang et al. [28] showed the
energy-dependent heterogeneous movement of telo-
meres. In other studies, it has been reported that hetero-
chromatin protein 1 (HP1a,H P 1 b,H P 1 g) accumulates
more rapidly into euchromatin-rich nuclear regions than
the HP1 subtypes of highly condensed heterochromatin
foci [29,30]. The recovery of HP1a protein is faster in
pluripotent mouse embryonic stem cells (mESCs) than
in differentiated cells [31]. Furthermore, the mobile frac-
tion of histones H2B and H3 is low compared to HP1
subtypes. However, an increased recovery after photo-
bleaching of H2B-GFP and H3-yellow fluorescent
protein (YFP) was measured in mESCs relative to differ-
entiated cells. This implies that the kinetics of chroma-
tin-related proteins are cell-type specific and dependent
on the level of chromatin condensation [31].
Previous studies have provided interesting data for
functionally important features of chromatin-related
proteins. The observations described above have led to
additional questions. Is the association of particular pro-
teins with nuclear domains of specific function the most
important criterion responsible for their kinetic proper-
ties or trajectories? Could molecular weight or protein
binding efficiency also influence protein diffusion into a
photobleached region? We analysed the trajectories and
kinetics of several chromatin-related proteins and deter-
mined the relationships between protein nuclear
arrangement, molecular weight, and recovery kinetics. In
addition, we asked whether the trajectories and kinetics
of particular proteins change in response to histone
hyperacetylation by the histone deacetylase (HDAC)
inhibitor trichostatin A (TSA) or after suppression of
transcription by actinomycin D.
Results
Cellular patterns of proteins studied
In this study, we analysed the dynamics of a select
group of proteins, which displayed the following cellular
patterns: subtypes of heterochromatin protein 1 (HP1a
and HP1b) preferentially accumulated at foci that colo-
calised with centromeric clusters, called chromocentres
(foci). HP1a (Figure 1 a1), and HP1b (Figure 1 a2), were
observed away from chromocentres (euchromatin) and
within nucleoli (arrows) (Figure 1a). The BMI1 protein
is a member of the protein regulator of cytokinesis 1
(PRC1) protein complex, which accumulated at Poly-
comb bodies (PcG) (frame in Figure 1b), but were also
observed outside of PcG bodies (Figure 1b). The TRF1
protein is a member of the shelterin complex associated
with telomeres and was preferentially bound to clusters
of telomeres (Figure 1c). RNA polymerase I large subu-
nit (RPA194), occupied a compartment of nucleoli
(Figure 1d). UBF is a member of the high mobility
group (HMG) proteins and exists as two spliced variants
(UBF1 and UBF2), which act as transcription enhancers.
Thus, UBF was found at the active promoters of riboso-
mal genes (rDNA) [11] (Figure 1e). We also analysed
the fluorescence recovery after photobleaching of his-
tones H2B (Figure 1 f1) and H4 (Figure 1 f2), represent-
ing the basic core histones responsible for general
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Page 2 of 17Figure 1 Cellular patterns of selected proteins. The dynamics of selected proteins were studied using GFP technology combined with
fluorescence recovery after photobleaching (FRAP). The following proteins were analysed: heterochromatin protein 1 (HP1a) (a1), (HP1b) (a2), B
lymphoma Mo-MLV insertion region 1 (BMI1) (b), telomeric-repeat binding factor 1 (TRF1) (c), RNA polymerase I large subunit (RPA194) (d),
upstream binding factor (UBF) (e), histones H2B (f1), H4 (f2), ubiquitin (Ub) (g), A-type lamins (h), histone demethylase JMJD2b (i), tumour
suppressor p53 (j), oncoprotein c-MYC (k), b-catenin (l), STAT1 (m), a-tubulin (n), PML protein (o), and Oct3/4 (p).
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By analysing the H2B pattern, it was possible to identify
chromatin condensation (heterochromatin) at the
nuclear periphery and around nucleoli. Moreover, it was
possible to distinguish potential dark regions of euchro-
matin (Figure 1 f1). The expression of ubiquitin-GFP
(Ub) was used to visualise highly ubiquitinated regions
of the genome, but this signal also appeared in the cyto-
plasm (Figure 1g). A-type lamins (lamin A and lamin C)
were preferentially located at the nuclear periphery and
partially in the nuclear interior (green signal inside
nucleus) (Figure 1h). We also analysed the dynamics of
full-length histone demethylase, JMJD2b, which was
equally distributed within interphase nuclei (Figure 1i).
Similarly, the tumour suppressor p53 (Figure 1j), onco-
protein c-MYC (Figure 1k), b-catenin (Figure 1l), and
ESC pluripotency-related signal transducer and activa-
tors of transcription 1 (STAT1) protein (Figure 1m)
were homogeneously distributed in the nucleoplasm.
Similar to a-tubulin (Figure 1n), STAT1 and b-catenin
appeared in the cytoplasm. Promyelocytic leukaemia
(PML) protein accumulated at PML bodies (Figure 1o)
and the octamer-binding transcription factor (Oct)3/4
protein (Figure 1p) was homogeneously dispersed
throughout the nucleoplasm in pluripotent mESCs. Tak-
ing into account the dynamic properties of all the pro-
teins studied and their molecular weights, we asked
whether the nuclear patterns influenced the kinetic
properties of these proteins, or if molecular weight was
the sole factor.
Correlation between molecular weight and kinetics of
chromatin-related proteins
We used regression analysis to determine whether the
kinetic properties of chromatin-related protein are influ-
enced by nuclear pattern and molecular weight. We com-
pared the molecular weights of 18 individual proteins
(tagged by GFP or mCherry; see Methods) with their
recovery of fluorescence 6 s after photobleaching. Addi-
tionally, we analysed the recovery of GFP; after 6 s [R6]i t
was 74% in the nucleus and 81% in the cytoplasm (data
not shown). We found no correlation when we studied
all proteins irrespective of their nuclear patterns (Figure
2a). However, when we grouped proteins according to
nuclear pattern, distinctions were observed between pro-
teins that were dispersed throughout the nucleoplasm
and those that accumulated at foci or nucleoli. For evenly
distributed proteins, the nuclear pattern acted together
with molecular weight to influence recovery time after
photobleaching (Figure 2b). We next determined whether
eliminating histones from this analysis influenced this
correlation. The following values were obtained from
regression analysis: analysis involving histones had a
Pearson’s correlation coefficient r = 0.68 and analysis
without histones showed r = 0.57 (data not shown). Both
values are significant for a = 0.05; thus, histone elimina-
tion did not influence the results.
In contrast, we showed that there was no significant
correlation between molecular weight and fluorescence
recovery for proteins that accumulated at foci (Figure 2c)
or nucleoli (Figure 2d). These results indicate that mole-
cular weight is not the sole factor in determining protein
kinetics, but that other factor can influence the dynamics
of some biologically active molecules.
Trajectories of HP1b, BMI1, and TRF1 foci are influenced
by histone hyperacetylation and suppression of
transcription
Real-time optical monitoring of cellular trajectories
showed differences in the movements of HP1b,B M I 1 ,
and TRF1 foci when cells were treated with TSA, vori-
nostat, or actinomycin D (Figures 3, 4, 5). Mouse fibro-
blasts are relatively flat; thus, we analysed the
trajectories in two dimensions. We studied the trajec-
tories of whole foci within the cell nucleus, but not the
trajectories of selected protein points within individual
foci. Heterogeneity was observed in the trajectories of
HP1b, BMI1, and TRF1 in all cases tested, but to a les-
ser extent for BMI1 in control cells (Figures 3, 4, 5). We
also observed differences in the trajectories, especially
when we distinguished between foci positioned in the
nuclear interior or the nuclear periphery (Figures 3 and
4). When we studied the tracks of HP1b at the nuclear
periphery, especially after actinomycin D treatment, the
area of the minimal enclosing ellipse of individual HP1b
foci was increased (Figure 3a and Table 1). The trajec-
tories of BMI1 foci at the nuclear periphery were slightly
reduced by TSA treatment (Figure 3b and Table 1).
However, the large-scale area of minimal enclosing
ellipses for TRF1 foci at the nuclear periphery were
increased after TSA addition, while the TRF1 trajec-
tories were reduced when cells were treated with actino-
mycin D (Figure 3c and Table 1). Changes in the TRF1
trajectories correspond well to changes in global tran-
scription and chromatin condensation, which are
increased after TSA, but decreased after actinomycin D
treatment.
In the nuclear interior, the trajectory of HP1b was not
remarkably influenced by TSA, compared to the control.
However, actinomycin D treatment subtly increased the
area occupied by HP1b ( F i g u r e4 aa n dT a b l e1 ) .O n
average, the trajectory of BMI1 at the nuclear interior
was relatively stable after TSA and actinomycin D treat-
ment (Figure 4b and Table 1). In addition, we observed
significant changes in interior TRF1 foci after TSA and
actinomycin D treatment (Figure 4c and Table 1): TSA
prolonged the track of TRF1, while actinomycin D
reduced the movement of TRF1 that appeared in the
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the average area occupied by the foci studied were
accompanied by changes in average velocities (compare
Table 1 with Table 2). However, different trends were
observed; increased average velocity was not always
accompanied by a larger area of minimal enclosing
ellipse, and vice versa.
Vorinostat, or suberoylanilide hydroxamic acid
(SAHA), is a potential clinical inhibitor of HDACs.
Thus, in parallel with TSA, we analysed the effect of
vorinostat on the GFP-HP1b, GFP-BMI1, and GFP-
TRF1 trajectories (Figures 3 and 4). Generally, we
observed that vorinostat had a more moderate effect on
protein trajectories than TSA (Figures 3 and 4). In the
case of HP1b vorinostat treatment reduced the area of
minimal enclosing ellipse at both the nuclear periphery
and interior (Figures 3 and 4). Vorinostat was also
found to effect protein movement when we analysed the
diffusion coefficient (D) and mean square displacement
(MSD) (Table 3 and Figure 5). Taken together, these
data show that vorinostat decreased the value of D in all
three proteins analysed (Table 3). These trends are also
expressed by MSD (see Figure 5).
The diffusion coefficient D for HP1b differed between
control cells and those treated by HDAC inhibitors
(TSA and vorinostat) and actinomycin D (Table 3).
Conversely, changes in BMI1 diffusion were not so pro-
nounced after selected treatments, whereas the diffusion
coefficient for TRF1 significantly changed after all treat-
ments (Table 3). Conclusions related to diffusion coeffi-
cient are closely related to trends expressed by the MSD
(Figure 5).
Recovery of fluorescence after photobleaching of HP1b,
BMI1, and TRF1 proteins after HDAC inhibition and
suppression of transcription by actinomycin D
We next asked whether histone hyperacetylation, caused
by the HDAC inhibitor TSA, or inhibition of transcription
Figure 2 Test of correlations between molecular weight and recovery time after photobleaching. (a) The kinetic properties after
photobleaching were studied for the following proteins: heterochromatin protein 1a (HP1a), HP1b, B lymphoma Mo-MLV insertion region 1
(BMI1), telomeric-repeat binding factor 1 (TRF1), RNA polymerase I large subunit (RPA194), upstream binding factor (UBF), H2B, H4, ubiquitin (Ub),
lamin A (central), JMJD2b, p53, c-MYC, b-catenin, STAT1, a-tubulin, PML, and Oct3/4. a-Tubulin was tagged with mCherry (35 kDa) and other
proteins were tagged with GFP (28 kDa). Molecular weights of individual proteins were compared by correlation analysis with the level of
relative fluorescence 6 s after photobleaching [R6]. (b) A correlation between molecular weight and fluorescence recovery of proteins was found
for proteins that were evenly dispersed throughout the nucleoplasm: HP1a, HP1b, BMI1, TRF1, H2B, H4, Ub, lamin A (central), JMJD2B, p53,
c-MYC, b-catenin, STAT1, a-tubulin, Oct3/4. (c) No correlation between molecular weight and fluorescence recovery for proteins that were
accumulated into foci: HP1a, HP1b, BMI1, TRF1, and PML. (d) No correlation was detected between molecular weight and fluorescence recovery
for proteins accumulated into nucleoli: HP1b, RPA194, UBF. Pearson’s correlation coefficient for (n-2) = 17 is 0.456; for (n-2) = 13 is 0.514; for
(n-2) = 3 is 0.878 and for (n-2) = 1 is 0.997. These values are for a = 0.05. Regression lines surrounded by 95% confidence intervals (dashed
curves) are shown in all panels except panel (d); to unify the axis scale, confidence intervals are not shown.
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Page 5 of 17Figure 3 Heterogeneity in the trajectory of heterochromatin protein 1b (HP1b), B lymphoma Mo-MLV insertion region 1 (BMI1), and
telomeric-repeat binding factor 1 (TRF1) foci at the nuclear periphery. Real-time monitoring of the foci trajectories is shown for HP1b (a),
BMI1 (b), and TRF1 (c) foci. Trajectories were mapped for foci that occupy the nuclear periphery. Heterogeneity in movement of all foci (blue
tracks) within an individual cell nucleus (grey) and events is shown. HP1b, BMI1, and TRF1 kinetics was studied in control cells, after TSA,
actinomycin D, and vorinostat treatment. Observation was performed over 20 min, scanning was performed every 2 s. Each trajectory (blue
curves) is bound by an ellipse enclosing the area of movement; the red star is the centre of the ellipse and the red circle is the start point of
movement.
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tin-related proteins, such as HP1b (Figure 6), BMI1
(Figure 7), and TRF1 (Figure 8). Immortalised mouse
embryonic fibroblasts (MEFs) were transfected with plas-
mids encoding HP1b or TRF1. Human U2OS cells stably
expressing BMI1 were also used in this analysis. HP1b
preferentially accumulated in centromeric clusters [32]. As
it is a Polycomb-related protein (PcG), BMI1 appeared in
Polycomb bodies [33], while TRF1, as a member of the
shelterin protein complex, accumulated at telomeric clus-
ters (summarised in [34]). The recovery times of the
selected proteins after photobleaching were measured in
approximately 20 identical cells, either throughout the
genome or when the proteins were accumulated in foci or
bodies. Moreover, since HP1b has been detected in
nucleoli [35], we also analysed the fluorescence recovery
after photobleaching of nucleolar HP1b.G e n e r a l l y ,p r o -
teins equally dispersed throughout the nucleoplasm recov-
ered more rapidly than proteins that were accumulated at
foci (Figures 6, 7, 8). When we bleached half of a nucleo-
lus, we found that movement was the same regardless of
whether the nucleolus had a high or low number of foci
(data not shown).
We confirmed that the fluorescence recovery kinetics
of HP1b is more rapid in euchromatin than in hetero-
chromatic chromocentres ([30] and Figure 6a). However,
the recovery time after photobleaching was similar for
HP1b in euchromatin away from foci (recovery after 10
Figure 4 Heterogeneity in the trajectory of heterochromatin protein 1b (HP1b), B lymphoma Mo-MLV insertion region 1 (BMI1), and
telomeric-repeat binding factor 1 (TRF1) foci at the nuclear interior. Real-time monitoring of the foci trajectories is shown for HP1b (a),
BMI1 (b), and TRF1 (c) foci. Trajectories were mapped for foci that occupy the nuclear interior. HP1b, BMI1, and TRF1 kinetics was studied in
control cells, after TSA, actinomycin D, and vorinostat treatment. Observation was performed over 20 min, scanning was performed every 2 s.
Each trajectory (blue curves) is bound by an ellipse enclosing the area of movement; the red star is the centre of the ellipse and the red circle is
the start point of movement.
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Page 7 of 17s[ R10] was 72%) and in nucleoli [R10] = 74% (Figure 6a).
Interestingly, after TSA treatment, the curves were iden-
tical for HP1b in euchromatin ([R10] = 76%), in hetero-
chromatic foci ([R10] = 75%), and in the nucleolus ([R10]
= 79%) (Figure 6b). When transcription was suppressed
by actinomycin D, the fluorescence recovery kinetics of
HP1b was significantly slower only in chromocentres
([R10] = 47%) (foci) (Figure 6c). We did not observe sta-
tistically significant changes when we compared the
kinetics of HP1b in euchromatin (Figure 6d) and within
nucleoli (Figure 6e) after TSA and actinomycin D
treatment. However, the recovery time after photo-
bleaching for the HP1b in foci significantly decreased
after actinomycin D and increased after TSA addition
(Figure 6f). Thus, we confirmed the effect of TSA on
heterochromatin regions, which has also been published
by Cheutin et al. [30]).
Fluorescence recovery of BMI1 was rapid when it was
diffuse in the nucleoplasm ([R10]=7 8 % )( F i g u r e7 a ) ,a n d
slower when it was accumulated in PcG bodies (foci)
([R10] = 36%) (Figure 7a). After TSA treatment, this trend
was similar, but the differences between the BMI1 mole-
cules outside ([R10] = 80%) and within PcG foci ([R10]=
28%) were more pronounced (Figure 7b). Moreover,
actinomycin D significantly reduced the fluorescence
recovery time after photobleaching of BMI1 protein
accumulated in foci ([R10] = 20%) (Figure 7c). We mea-
sured a slower recovery for BMI1 away from PcG bodies
when the cells were treated with actinomycin D (Figure
7d), but this was not statistically significant. Interestingly,
the BMI1 in PcG bodies recovered more slowly after
TSA treatment, but the difference was not as strong as
after actinomycin D treatment (Figure 7e).
The telomeric TRF1 protein also showed significant
differences depending on whether or not TRF1 was
accumulated in foci. TRF1 foci are likely clusters
consisting of several telomeres, consistent with the
observation that cells expressing GFP-TRF1 had fewer
TRF1-positive foci than telomeres. We measured [R10]=
81% for TRF1 outside of foci (likely the unbound form),
and [R10] = 60% for TRF1 localised to telomere clusters
(Figure 8a). Changes in TRF1 fluorescence recovery
time were also observed in cells treated with TSA or
actinomycin D (Figure 8b,c). After TSA treatment, [R10]
= 72% for unbound TRF1 and [R10] = 52% for TRF1
Figure 5 Mean square displacement (MSD) plots describe the
foci movement. The simulated MSD is represented by solid line,
the theoretical MSD is not shown, but the MSD ± SD are dashed
lines.
Table 1 Area of heterochromatin protein 1b (HP1b), B lymphoma Mo-MLV insertion region 1 (BMI1), and telomeric-
repeat binding factor 1 (TRF1) foci
Area of minimal enclosing ellipse (μm
2)
HP1b BMI1 TRF1
Peripheral foci: control 0.22 ± 0.12 (n = 10) 0.17 ± 0.09 (n = 4) 0.19 ± 0.06 (n = 8)
Peripheral foci: TSA 0.13 ± 0.10 (n = 19) 0.02 ± 0.02 (n = 12) 0.7 ± 0.54 (n = 15)
Peripheral foci: actinomycin D 0.59 ± 0.48 (n = 4) 0.09 ± 0.05 (n = 5) 0.08 ± 0.05 (n = 20)
Peripheral foci: vorinostat 0.17 ± 0.10 (n = 23) 0.17 ± 0.22 (n = 13) 0.28 ± 0.47 (n = 29)
Central foci: control 0.15 ± 0.07 (n = 7) 0.11 ± 0.05 (n = 10) 0.27 ± 0.21 (n = 8)
Central foci: TSA 0.16 ± 0.09 (n = 16) NA (n = 0) 0.65 ± 0.42 (n = 8)
Central foci: actinomycin D 0.69 ± 0.46 (n = 6) 0.07 ± 0.06 (n = 5) 0.05 ± 0.02 (n = 11)
Central foci: vorinostat 0.21 ± 0.12 (n = 13) 0.09 ± 0.03 (n = 10) 0.15 ± 0.17 (n = 18)
Area mean: control 0.19 ± 0.11 0.13 ± 0.07 0.23 ± 0.16
Area mean: TSA 0.14 ± 0.09 - 0.68 ± 0.49
Area mean: actinomycin D 0.65 ± 0.44 0.08 ± 0.05 0.06 ± 0.04
Area mean: vorinostat 0.18 ± 0.11 0.14 ± 0.17 0.23 ± 0.39
Mean values ± standard deviations were calculated for all foci found in one living cell. Number of foci analysed is shown in brackets. Central foci were positioned
in <60% of nuclear radius, as peripheral foci were considered those located at >60% the nuclear radius. TSA = trichostatin A.
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ted with actinomycin D, [R10] = 64% for TRF1 outside
of foci, but for TRF1 within foci, [R10] = 37% (Figure
8c). We also compared TRF1 fluorescence recovery after
photobleaching in untreated control cells, and TSA-trea-
ted and actinomycin D-treated cells. After actinomycin
D treatment, fluorescence recovery time after photo-
bleaching was not significantly reduced for TRF1 outside
of foci (Figure 8d). However, TRF1 recovery was signifi-
cantly reduced within foci, particularly in cells treated
with actinomycin D (Figure 8e).
We also measured the effect of vorinostat on the
fluorescence recovery of selected proteins (Figure 9).
The inhibitory effect of vorinostat was confirmed by
western blot showing increased H3K9 acetylation
(Figure 9a). Despite the effect of vorinostat on histone
acetylation, FRAP analysis showed only subtle changes
in the fluorescence recovery of HP1b,B M I 1 ,a n dT R F 1
when we distinguished proteins in foci and away from
foci (Figure 9b-d). Thus, we confirmed our previous
conclusion that vorinostat has a more moderate effect
on protein mobility than does TSA.
Kinetic modelling of HP1b, RPA194, and UBF dynamics
with modulated transcription levels
Using the FRAP technique and subsequent statistical
analysis, we compared the fluorescence recovery kinetics
of HP1b, polymerase I subunit RPA194, and UBF in the
nucleoli of untreated MEF cells and those treated with
TSA and actinomycin D (Figure 10). Within nucleoli,
HP1b ([R10] = 74%) recovered more rapidly than
RPA194 ([R10] = 53%) and UBF ([R10] = 41%) (compari-
s o no fc o n t r o l si nF i g u r e1 0 a - c ) .H P 1 b recovery time
after photobleaching in nucleoli was not significantly
changed by hyperacetylation or the reduced transcrip-
tion levels caused by actinomycin D (Figure 10a). How-
ever, the recovery fluorescence for RPA194 was reduced
after actinomycin D treatment, but not after TSA cell
stimulation (Figure 10b). In the case of UBF, actinomy-
cin D treatment completely reduced UBF diffusion
(Figure 10c) and TSA also significantly decreased the
diffusion of UBF protein (Figure 10c). Overall, our
results show that actinomycin D significantly decreased
protein mobility after photobleaching, while the effects
of TSA were protein-specific and nuclear pattern-
specific.
Discussion
In the present work, we have uncovered a link between
the dynamics and trajectories of chromatin-related pro-
teins, and transcriptional regulation by TSA or an inhi-
bitor of transcription elongation, actinomycin D. We
have also addressed the effect of vorinostat (SAHA),
another HDAC inhibitor that has promising therapeutic
applications in oncology.
Cheutin et al. [30] reported distinct kinetics for HP1
subtypes (HP1a,H P 1 b,H P 1 g)d e p e n d i n go nw h e t h e r
Table 3 Diffusion coefficient of heterochromatin protein
1b (HP1b), B lymphoma Mo-MLV insertion region 1
(BMI1), and telomeric-repeat binding factor 1 (TRF1) foci
Foci Diffusion coefficient D (10
-4 μm
2/s)
HP1b BMI1 TRF1
Control 3.05 0.74 1.61
TSA 1.05 0.04 0.95
actinomycin D 4.28 0.42 0.11
vorinostat 0.90 0.37 0.73
TSA = trichostatin A.
Table 2 Average velocity of heterochromatin protein 1b (HP1b), B lymphoma Mo-MLV insertion region 1 (BMI1), and
telomeric-repeat binding factor 1 (TRF1) foci
Average velocity (μm/s)
HP1b BMI1 TRF1
Peripheral foci: control 0.034 ± 0.007 0.017 ± 0.003 0.024 ± 0.005
Peripheral foci: TSA 0.024 ± 0.011 0.012 ± 0.005 0.046 ± 0.012
Peripheral foci: actinomycin D 0.024 ± 0.003 0.016 ± 0.005 0.021 ± 0.015
Peripheral foci: vorinostat 0.020 ± 0.003 0.020 ± 0.007 0.026 ± 0.010
Central foci: control 0.036 ± 0.018 0.015 ± 0.003 0.021 ± 0.004
Central foci: TSA 0.028 ± 0.017 NA 0.050 ± 0.020
Central foci: actinomycin D 0.022 ± 0.003 0.013 ± 0.003 0.018 ± 0.003
Central foci: vorinostat 0.020 ± 0.004 0.017 ± 0.003 0.026 ± 0.010
Velocity mean: control 0.035 ± 0.012 0.016 ± 0.003 0.023 ± 0.005
Velocity mean: TSA 0.026 ± 0.014 - 0.047 ± 0.015
Velocity mean: actinomycin D 0.023 ± 0.003 0.015 ± 0.005 0.020 ± 0.010
Velocity mean: vorinostat 0.020 ± 0.004 0.018 ± 0.005 0.026 ± 0.010
NA indicates that it was not possible to recognise centrally positioned foci using automated computer analysis.
TSA = trichostatin A.
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are in euchromatin. Meshorer et al. [31] published that
the recovery of heterochromatin-related HP1a is more
rapid in mESCs than in terminally differentiated neu-
rons derived from mESCs. Here, we report that in
nucleoli, where HP1b appears in dispersed form [35],
the kinetics of HP1b are similar to those described by
Cheutin et al. [30] at euchromatin (Figure 6d,e).
According to these results, it is evident that protein den-
sity and protein affiliation with heterochromatin or
euchromatin influence protein mobility. This is illu-
strated by the observations that proteins recovered more
slowly when accumulated in foci (HP1b,B M I 1 ,T R F 1 )
than when evenly dispersed throughout the nucleoplasm
(Figures 6, 7, 8, 9). Moreover, the values for fluorescence
recovery correlated with protein molecular weight only
for proteins that were homogeneously distributed
throughout the nucleoplasm (Figure 2b). These data
suggest that it is not molecular weight alone, but mole-
cular weight together with nuclear pattern that influ-
ences protein kinetics. This is supported by the lack of
correlation between molecular weight and recovery of
18 proteins that were analysed irrespective of nuclear
pattern (Figure 2a). Our results are consistent with
Figure 6 Heterochromatin protein 1b (HP1b) dynamics in different nuclear regions. The kinetic properties of HP1b proteins are provided
for HP1b accumulated in foci of heterochromatin, nuclear regions outside of foci (likely euchromatin), and HP1b accumulated in nucleoli. This
analysis was performed in (a) control MEFs, (b) TSA-treated MEFs, and (c) actinomycin D-treated MEFs. Comparison of HP1b in control (black
dots), TSA-treated cells (triangles), and actinomycin D-stimulated (squares) cells. Proteins were analysed (d) in euchromatin or away from foci; e.g.
in interchromatin space; (e) nucleoli, and (f) in foci of heterochromatin.
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sion coefficients do not depend on molecular weight.
However, Braga et al. [37] published that diffusion coef-
ficients are lower in the nucleoplasm for higher molecu-
lar weight dextran, which is a temperature-dependent
effect. Based on these results, it seems that biologically
inactive molecules move differently than physiologically
active proteins of similar size [38-40].
We also showed that, for all examples tested, suppres-
sion of transcription by actinomycin D had a strong
impact on HP1b, BMI1, and TRF1 mobility. It is evident
that actinomycin D, an agent that intercalates into dou-
ble stranded DNA, robustly disturbed nuclear structure
and induced changes in the mobility of proteins. Intrigu-
ingly, we observed more pronounced differences in the
recovery time of HP1b and BMI1 in heterochromatic
foci than in euchromatin regions after treatment with
actinomycin D or HDAC inhibitor (Figures 6 and 7).
For the most part, distinct global transcription levels
were associated with decreased recovery kinetics of the
studied proteins. Generally, protein residence time was
more frequently reduced when core histones were
hyperacetylated ([26]; Figures 7b,e and 8e). Similarly to
Cheutin et al. [ 3 0 ] ,w eo b s e r v e dt h a tH P 1 b was an
exception to this rule. In this case, histone hyperacetyla-
tion-induced by TSA significantly increased the mobility
of HP1b in heterochromatic foci (Figure 6f). This sup-
ports previous data on the effect of HDAC inhibitors
(TSA and sodium butyrate) on heterochromatin; HDAC
inhibitors disturb the nuclear arrangement of HP1
Figure 7 B lymphoma Mo-MLV insertion region 1 (BMI1) dynamics in different nuclear regions. Fluorescence recovery time after
photobleaching was studied for BMI protein accumulated in PcG bodies and outside of PcG bodies in (a) control MEFs; (b) TSA-treated MEFs;
and after actinomycin D treatment (c). Comparison of BMI1 in control (black dots), TSA-treated (triangles), and actinomycin D-stimulated
(squares) cells in nuclear regions (d) devoid of PcG bodies, and (e) in PcG bodies.
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erochromatin [41,42]. In contrast, we show here that
vorinostat had a more moderate effect on protein mobi-
lity than TSA. Thus, the analysis of protein mobility
after cytostatic treatments might reveal important side
effects of clinically used drugs.
Interestingly, when we increased the transcriptional
activity of ribosomal genes along with increased histone
acetylation by treating cells with TSA [35], we observed
no effect on RPA194 recovery time, similar to what was
observed for HP1b in nucleoli (Figure 10a,b). However,
a significantly decreased recovery time was observed for
UBF after TSA treatment (Figure 10c). Because RPA194,
UBF, and HP1b proteins are all associated with active
transcription of ribosomal genes [11,35], these distinc-
tions may be consequences of protein quantity at parti-
cular genomic regions and/or related to protein binding
efficiency to other proteins or DNA in this region. Simi-
larly, the local concentrations of proteins can influence
the mobilisation and kinetics of particular proteins, as
discussed in two papers by Ayoub et al. [43,44], espe-
cially for HP1b recruited to UV-damaged chromatin.
Another explanation is that the recovery kinetics after
photobleaching may be influenced by cell cycle changes.
Figure 8 Telomeric-repeat binding factor 1 (TRF1) dynamics at telomeric regions and nuclear regions away from telomeres.
Fluorescence recovery time after photobleaching was studied for TRF1 protein accumulated in telomeric clusters (triangle) and away from
telomeres (black dots). The analysis was performed in (a) control MEFs; (b) TSA-treated MEFs and (c) after actinomycin D treatment. Additional
comparison was performed for TRF1 in control (black dots), TSA-treated (triangles), and actinomycin D-stimulated (squares) cells in nuclear
regions (d) absent of telomeric clusters (unbounded protein), and (e) for TRF1 foci associated with clusters of telomeres.
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transcription increases during the cell cycle [19]. In S-
phase, there is a reduced recovery after photobleaching
of RPA194 compared with G1 cells [19]. Similarly, the
low recovery properties of histone H2B and H3 ([31],
and Figure 2a,b) were significantly reduced when prolif-
erating mESCs were induced to neuronal differentiation,
characterised by a cell cycle block in G0 phase [31]. As
stated by Melcer and Meshorer [45], this phenomenon
is not without exception. For example, the recovery
kinetics of histone H3.3 is similarly hypodynamic in
Figure 9 Heterochromatin protein 1b (HP1b), B lymphoma Mo-
MLV insertion region 1 (BMI1), and telomeric-repeat binding
factor 1 (TRF1) fluorescence recovery after vorinostat
treatment. (a) Western blot analysis of H3K9 acetylation in MEFs
and GFP-BMI-U2OS cells treated by vorinostat. (b) Fluorescence
recovery of HP1b accumulated into foci or outside of foci in control
and vorinostat-treated MEFs. (c) Fluorescence recovery after
photobleaching (FRAP) data of BMI1 accumulated into PcG bodies
or outside of PcG bodies in control and vorinostat-treated GFP-BMI-
U2OS cells. (d) Fluorescence recovery of TRF1 associated with
telomeres or dispersed in interchromatin space of control and
vorinostat-treated MEFs.
Figure 10 Heterochromatin protein 1b (HP1b), RNA polymerase
I large subunit (RPA194), and upstream binding factor (UBF)
kinetics within nucleoli. Fluorescence recovery time after
photobleaching was studied for (a) HP1b, (b) RPA194, and (c) UBF
proteins accumulated into nucleoli. Comparison was performed for
given proteins studied in control (black dots), TSA-treated (triangles),
and actinomycin D-stimulated (squares) MEFs.
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tion. Moreover, no differences in histone H1
o kinetics
were observed during different cell cycle stages [31].
Our experiments were directed towards the detailed
detection of trajectories of selected protein foci. We also
measured a correlation between TRF1 foci trajectory
and transcriptional activity, but it was not upheld for
HP1b and BMI1 (Figures 3, 4, 5). This is similar to data
published for nuclear gene positioning with respect to
gene expression. For example Meaburn and Misteli [46]
identified several genes that are spatially repositioned
during breast cancer tumorigenesis, but observed gene
activity-independent genome repositioning in the early
stages of tumour formation. Recently, we showed that
the nuclear radial position of the pluripotency gene
Oct3/4 did not change when downregulated [47]. Thus,
it seems that nuclear radial position is highly gene speci-
fic and likely depends on the transcriptional activity of
surrounding chromatin and/or, as stated by Küpper et
al. [48], radial chromatin positioning is shaped by local
gene density, not by gene expression.
Together, the trajectories of HP1b,B M I 1 ,a n dT R F 1
foci were, in many cases, influenced by histone hypera-
cetylation and by suppression of transcription by actino-
mycin D (Figures 3, 4, 5). However, the localised
dynamics or extended dynamics of other nuclear
domains, such as PML bodies, are not changed after
inhibition of RNA polymerase II by a-amanitin [49].
Here, we found that a protein trajectory was dependent
on foci positioning; it matters whether the foci were
located at the nuclear periphery or in the nuclear inter-
ior (Figures 3 and 4). Heterogeneity in the mobility of
protein foci has also been reported by Guan et al. [50]
for a1B-adrenoceptor in living cells. Moreover,
increased energy dependent motion was observed by
Wang et al. [28] for shorter telomeres when compared
with longer and uncapped telomeres. Here, we show
that both the trajectory and the average velocity were
specific to nuclear positioning for HP1b,B M I 1 ,a n d
TRF1 foci (Table 1). This heterogeneity in foci move-
ment is consistent with the observation of ‘calm’ and
‘jittering’ telomeres in live cells [28]. Similarly, Muratani
et al. [49] have published velocity differences between
individual PML bodies. Trajectories of PML bodies were
defined as quasilinear, which is distinct from the trajec-
tories of HP1b,B M I 1 ,a n dT R F 1f o c i( F i g u r e s3 ,4 ,5 ) .
These data demonstrate protein-specific kinetics and
trajectories that likely reflect several biological events.
Conclusions
We have described protein dynamics that can be influ-
enced by several factors, including binding and release
constants, residence times, diffusion coefficients [40],
chromatin condensation [30], cell differentiation [45],
and cell cycle-dependent transcriptional level [19]. In
addition, Odenheimer et al. [51], suggest there are
strong effect of chromatin nanostructure on local mobi-
lity. In our experimental model, no single factor was
directly responsible for slow or fast fluorescence recov-
ery after photobleaching. Thus, we propose that protein
dynamics are likely influenced by several factors and cel-
lular processes that combine to determine the kinetic
properties of chromatin-related proteins.
Methods
Cell culture
Immortalised wild-type (wt) MEFs originated in the
Laboratory of Professor Thomas Jenuwein, Max-Planck
Institute of Immunobiology and Epigenetics, Freiburg,
Germany. HeLa cells expressing histone H2B-GFP were
a generous gift from Dr Marion Cremer (Ludwig-
Maximilians University, Munich, Germany) and photo-
convertible Dendra2 was used to label histone H4 in
HepG2 cells (obtained from Professor Ivan Raška, Insti-
tute of Cellular Biology and Pathology, First Faculty of
Medicine, Charles University, Prague, Czech Republic).
U2OS cells expressing BMI1-GFP were a generous gift
from Associate Professor Dušan Cmarko (Institute of
Cellular Biology and Pathology, First Faculty of Medi-
cine, Charles University, Prague, Czech Republic).
Dr Paul Verbruggen (Swammerdam Institute for Life
Sciences, University of Amsterdam, Amsterdam, The
Netherlands) provided 3T3 cells with stable HP1b
expression. The majority of cells were cultivated in
high-glucose Dulbecco’s modified Eagle medium
(DMEM) containing 10% sera, but MEFs were cultivated
according to Harničarová Horáková et al. [35] and Den-
dra-HepG2 were grown in low-glucose DMEM supple-
mented with 10% sera. When the cultures reached 70%
confluence, the cells were treated with a final concentra-
tion of 100 nM trichostatin A (TSA; Sigma-Aldrich, St
Louis, MO, USA) and 0.5 μg/ml actinomycin D
(#A9415, Sigma-Aldrich). The hyperacetylation effects of
TSA have been verified elsewhere [41,52] and actinomy-
cin D is a commonly used reagent to block transcription
elongation mediated by RNA polymerases [20,21,53].
T h em E S Cl i n e ,G O W T 1( ag e n e r o u sg i f tf r o m
Hitoshi Niwa, Laboratory for Pluripotent Stem Cell Stu-
dies, RIKEN Center for Developmental Biology, Kobe,
Japan), was cultivated in standard mESC medium (Glas-
gow minimum essential medium (GMEM) + 10% foetal
calf serum (FCS)) with leukaemia inhibitory factor (LIF).
These cells were maintained in the presence of puromy-
cin (1.5 μg/ml) to select for Oct3/4 positive undifferen-
tiated stem cells. All cell cultures were maintained at
37°C in a humidified atmosphere containing 5% CO2.
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The plasmids were transformed into Escherichia coli
DH5a for amplification. Plasmid DNA was isolated
using the QIAGEN Large-Construct kit (#12462; QIA-
GEN, Bio-Consult, Prague, Czech Republic). For trans-
fection of MEFs we used the METAFECTENE PRO
system (Biontex Laboratories GmbH, Planegg, Ger-
many). The following plasmids were used in this study:
JMJD2b-GFP (obtained from Professor Thomas Jenu-
wein and Dr Nicholas Shukeir, Max-Planck Institute of
Immunobiology, Freiburg, Germany); HP1a-GFP and
HP1b-GFP (from the laboratory of Dr Tom Misteli,
National Institutes of Health, Bethesda, MD, USA);
RPA194-GFP (Addgene Inc., Cambridge, MA, USA;
#17660); UBF-GFP (Addgene; #17656); Ubiquitin-GFP
(Addgene; #11928); p53-GFP (Addgene; #12091);
pmCherry-alpha-tubulin-IRES-puro2 (Addgene; #1360);
lamin A-GFP (Addgene; #17662); c-myc-GFP (a gift
from Dr Hiroyoshi Ariga, Hokkaido University, Gradu-
ate School of Pharmaceutical Sciences, Kita-Ku, Sap-
poro, Japan), b-catenin-enhanced GFP and STAT1-GFP
(gifts from Dr Vítězslav Bryja and Dr Jiří Pacherník,
Faculty of Sciences, Masaryk University, Brno, Czech
Republic). GFP-hTRF1-pS6 5 T - C 1w a sag i f tf r o mD rC
M Counter, Duke University Medical Center, Durham,
NC, USA. GFP-PML was obtained from Douglas Durso,
Customer Service Representative, Roche NimbleGen,
Inc., Madison, WI, USA. pEGFP-C1 cloning plasmid
was purchased from Clontech Laboratories, Inc. (Moun-
tain View, CA, USA).
Single particle tracking analysis
Time series of images were acquired on a confocal Leica
TSC SP 5× microscope (Leica, Mannheim, Germany).
We captured images every 2.6 s for 20 min. The image
analysis was performed using Matlab software
http://www.mathworks.com/products/matlab/. Each
frame was cropped to contain a single cell. Weighted
centres of foci were computed for every frame (see
below). The centres formed point sets, which were used
to compensate for cellular movement, as described in
[54]. It was impossible to localise all foci in all frames
(mostly due to out-of-focus motion). Therefore, the tra-
jectories were made in two steps: (1) all corresponding
points in successive frames were linked together. The
correspondence was identified by a point-based align-
ment algorithm. This step produced many foci sub-
tracks. In this step, we determined the area of the
smallest ellipse required to enclose all points in each
subtrack. (2) We combined subtracks in one track if
their minimal ellipses intersected and followed each
other in time. The collection of subtracks defined the
trajectory of a focus. We calculated the average velocity
of the foci as the length of all trajectory subtracks
divided by the sum of the subtracks’ time spans. We
measured the area of the minimal enclosing ellipse of all
trajectory points. We studied the foci trajectories in the
interior of nucleus, as well as at the nuclear periphery.
The trajectories that had a local radius less of than 60%
for the initial frame were taken to be the central trajec-
tory. Local radius has been defined elsewhere [55].
We calculated the weighted centres of the foci using
the following procedure. First, to remove noise, each
frame of a sequence was filtered through a median filter
with a circular window of 7 pixels. The image was then
smoothed by convolution with Gaussian kernel (s =3 ) .
Next, we computed the morphological h-dome trans-
form with manually selected h value. Only domes con-
taining a pixel intensity exactly equal to h were
considered objects of interest. This was achieved using
morphological reconstructions of h-dome images from
seeds corresponding to pixels of intensity h.F i n a l l y ,w e
computed the weighted centres within h-domes of
detected objects (foci).
To compute the local radius of points, we had to seg-
ment the nucleus, which was performed using the fol-
lowing algorithm. First, the image was smoothed by
convolution with a Gaussian kernel s = 10), and then
the threshold was adjusted using the chord method [56].
Morphological closing of a suitable radius was per-
formed to fill the holes.
We calculated MSD and diffusion coefficient as pre-
viously described [57]. We used a modified MSD for-
mula for sequences with missing probes as previously
d e s c r i b e d[ 5 7 ] .T h eM S Dc u r v ew a sc a l c u l a t e df o ra l l
trajectories up to the time lag of 100 frames (260 s). We
present average curves for different cells in Figure 5.
The diffusion coefficient was estimated by linear fit-
ting to the MSD curve. The optimal number of fitting
points was determined using the iterative scheme pro-
posed in [57]. We calculated the diffusion coefficient
from the average MSD curves.
Live cell imaging, FRAP analysis, and statistics
Cells growing on 50-mm glass-bottomed dishes (MatTek,
Corporation, Ashland, MA, USA; #P50G-0-30-F) were
placed in a cultivation hood (EMBL, Heidelberg, Germany)
with a stable temperature of 37°C and 5% CO2.F o rl i v e
cell studies, we used a confocal Leica TSC SP-5× micro-
scope, equipped with a white light laser (470 to 670 nm);
argon laser (488 nm), and UV lasers (355 nm and
405 nm); 64× magnification and numerical aperture NA =
1.4 were used. The movement of individual cells and chro-
matin-related proteins, either accumulated in distinct foci
or dispersed throughout the nucleoplasm, was monitored
using Leica LAS AF software (version 2.1.2). For trajectory
analysis, the cells were monitored for 20 min; scanning
was performed every 2 s. For FRAP, GFP was excited at
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molecules were bleached at defined regions of interest
(ROI) (2 μm
2). Bleaching was performed with a 488-nm
argon laser for 1.2 s. For scanning, we used 10% laser
intensity and for FRAP we used 100% laser power. To
minimise the laser instability that can be caused by exter-
nal temperature, the room temperature was stabilised
using a highly precise air conditioner (room temperature
was 21°C to 22°C). Moreover, a particular set of experi-
ments was analysed by FRAP in a single day to minimise
the effects of laser instability. Prebleaching was set to five
frames (each frame is 0.66 s), and the rate of fluorescence
recovery provided information about the rate at which the
fluorescent molecules moved into the bleached region.
The cells were monitored over 0.66 s intervals, for 25 s.
To study correlations, we used linear regression analy-
sis as a statistical tool in the SigmaPlot software (version
8.0; SPSS, Chicago, IL, USA). Potential correlation
between molecular weight (MW) and fluorescence
recovery after photobleaching was evaluated by the
Pearson’s product-moment correlation coefficient (r).
We constructed linear regression curves and a confi-
dence interval around (r) that showed 95% probability of
statistically significant results.
Acknowledgements
This work was supported by the Ministry of Education Youth and Sports of
the Czech Republic; the research projects LC535, LC06027, ME919, and by
the Academy of Sciences of the Czech Republic; projects AVOZ50040702
and AVOZ50040507. This work was also supported by EU project COST
TD09/05 and by Grant Agency of Czech Republic, project P302/10/1022.
Many thanks the scientists (mentioned in Methods section) who provided
cells and/or plasmids and Dr Jiří Pacherník for GOWT1 mESC cultivation. We
are also grateful to BioScience Writers (Houston, TX, USA) for the critical
linguistic revision of our manuscript.
Author details
1Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno,
Czech Republic.
2Faculty of Informatics, Masaryk University, Brno, Czech
Republic.
Authors’ contributions
LS was responsible for cell cultivation, transfection, FRAP experiments,
statistics, and regression analysis, and writing the manuscript. EB conceived
experiments and wrote the manuscript. PM and OD analysed trajectories of
selected proteins and calculated diffusion coefficients and MSD; they are
responsible for the results in Figures 3, 4, 5 and Tables 1, 2, 3. The algorithm
for trajectories was provided by OD. SL is responsible for the western blot
data. SK interpreted data and provided financial support.
Competing interests
The authors declare that they have no competing interests.
Received: 1 December 2010 Accepted: 18 March 2011
Published: 18 March 2011
References
1. Belmont AS: Visualizing chromosome dynamics with GFP. Trends Cell Biol
2001, 11:250-257.
2. Meshorer E: Imaging chromatin in embryonic stem cells. StemBook The
Stem Cell Research Community; 2008 [http://www.ncbi.nlm.nih.gov/books/
NBK27072/].
3. Misteli T: Beyond the sequence: cellular organization of genome
function. Cell 2007, 128:787-800.
4. Lanctot C, Cheutin T, Cremer M, Cavalli G, Cremer T: Dynamic genome
architecture in the nuclear space: regulation of gene expression in three
dimensions. Nat Rev Genet 2007, 8:104-115.
5. Mattout A, Meshorer E: Chromatin plasticity and genome organization in
pluripotent embryonic stem cells. Curr Opin Cell Biol 2010, 22:334-341.
6. Branco MR, Pombo A: Intermingling of chromosome territories in
interphase suggests role in translocations and transcription-dependent
associations. PLoS Biol 2006, 4:e138.
7. Cremer T, Cremer C: Chromosome territories, nuclear architecture and
gene regulation in mammalian cells. Nat Rev Genet 2001, 2:292-301.
8. Probst AV, Almouzni G: Pericentric heterochromatin: dynamic
organization during early development in mammals. Differentiation 2008,
76:15-23.
9. Blackburn EH: Telomeres and telomerase: their mechanisms of action
and the effects of altering their functions. FEBS Lett 2005, 579:859-862.
10. Blasco MA: Telomere length, stem cells and aging. Nat Chem Biol 2007,
3:640-649.
11. Prieto JL, McStay B: Pseudo-NORs: a novel model for studying nucleoli.
Biochim Biophys Acta 2008, 1783:2116-2123.
12. Raska I, Shaw PJ, Cmarko D: New insights into nucleolar architecture and
activity. Int Rev Cytol 2006, 255:177-235.
13. Raska I, Shaw PJ, Cmarko D: Structure and function of the nucleolus in
the spotlight. Curr Opin Cell Biol 2006, 18:325-334.
14. Alcobia I, Quina AS, Neves H, Clode N, Parreira L: The spatial organization
of centromeric heterochromatin during normal human lymphopoiesis:
evidence for ontogenically determined spatial patterns. Exp Cell Res 2003,
290:358-369.
15. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI: The
multifunctional nucleolus. Nat Rev Mol Cell Biol 2007, 8:574-585.
16. McStay B, Grummt I: The epigenetics of rRNA genes: from molecular to
chromosome biology. Annu Rev Cell Dev Biol 2008, 24:131-157.
17. Grummt I: Life on a planet of its own: regulation of RNA polymerase I
transcription in the nucleolus. Genes Dev 2003, 17:1691-1702.
18. Russell J, Zomerdijk JC: RNA-polymerase-I-directed rDNA transcription, life
and works. Trends Biochem Sci 2005, 30:87-96.
19. Gorski SA, Snyder SK, John S, Grummt I, Misteli T: Modulation of RNA
polymerase assembly dynamics in transcriptional regulation. Mol Cell
2008, 30:486-497.
20. Perry RP, Kelley DE: Inhibition of RNA synthesis by actinomycin D:
characteristic dose-response of different RNA species. J Cell Physiol 1970,
76:127-139.
21. Sobell HM: Actinomycin and DNA transcription. Proc Natl Acad Sci USA
1985, 82:5328-5331.
22. Weiland Y, Lemmer P, Cremer C: Combining FISH with localisation
microscopy: super-resolution imaging of nuclear genome
nanostructures. Chromosome Res 2011, 19:5-23.
23. Egner A, Verrier S, Goroshkov A, Soling HD, Hell SW: 4Pi-microscopy of
the Golgi apparatus in live mammalian cells. J Struct Biol 2004,
147:70-76.
24. Schermelleh L, Carlton PM, Haase S, Shao L, Winoto L, Kner P, Burke B,
Cardoso MC, Agard DA, Gustafsson MG, Leonhardt H, Sedat JW:
Subdiffraction multicolor imaging of the nuclear periphery with 3D
structured illumination microscopy. Science 2008, 320:1332-1336.
25. Hell SW, Wichmann J: Breaking the diffraction resolution limit by
stimulated emission: stimulated-emission-depletion fluorescence
microscopy. Opt Lett 1994, 19:780-782.
26. Misteli T: Protein dynamics: implications for nuclear architecture and
gene expression. Science 2001, 291:843-847.
27. Hernandez-Munoz I, Lund AH, van der Stoop P, Boutsma E, Muijrers I,
Verhoeven E, Nusinow DA, Panning B, Marahrens Y, van Lohuizen M: Stable
X chromosome inactivation involves the PRC1 polycomb complex and
requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3
ligase. Proc Natl Acad Sci USA 2005, 102:7635-7640.
28. Wang X, Kam Z, Carlton PM, Xu L, Sedat JW, Blackburn EH: Rapid telomere
motions in live human cells analyzed by highly time-resolved
microscopy. Epigenetics Chromatin 2008, 1:4.
29. Festenstein R, Pagakis SN, Hiragami K, Lyon D, Verreault A, Sekkali B,
Kioussis D: Modulation of heterochromatin protein 1 dynamics in
primary Mammalian cells. Science 2003, 299:719-721.
Stixová et al. Epigenetics & Chromatin 2011, 4:5
http://www.epigeneticsandchromatin.com/content/4/1/5
Page 16 of 1730. Cheutin T, McNairn AJ, Jenuwein T, Gilbert DM, Singh PB, Misteli T:
Maintenance of stable heterochromatin domains by dynamic HP1
binding. Science 2003, 299:721-725.
31. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T:
Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic
stem cells. Dev Cell 2006, 10:105-116.
32. Minc E, Allory Y, Worman HJ, Courvalin JC, Buendia B: Localization and
phosphorylation of HP1 proteins during the cell cycle in mammalian
cells. Chromosoma 1999, 108:220-234.
33. Sparmann A, van Lohuizen M: Polycomb silencers control cell fate,
development and cancer. Nat Rev Cancer 2006, 6:846-856.
34. Sykorova E, Fajkus J: Structure-function relationships in telomerase genes.
Biol Cell 2009, 101:375-392.
35. Horakova AH, Bartova E, Galiova G, Uhlirova R, Matula P, Kozubek S:
SUV39h-independent association of HP1 beta with fibrillarin-positive
nucleolar regions. Chromosoma 2010, 119:227-241.
36. Jacobson K, Wojcieszyn J: The translational mobility of substances within
the cytoplasmic matrix. Proc Natl Acad Sci USA 1984, 81:6747-6751.
37. Braga J, Desterro JM, Carmo-Fonseca M: Intracellular macromolecular
mobility measured by fluorescence recovery after photobleaching with
confocal laser scanning microscopes. Mol Biol Cell 2004, 15:4749-4760.
38. Houtsmuller AB, Rademakers S, Nigg AL, Hoogstraten D, Hoeijmakers JH,
Vermeulen W: Action of DNA repair endonuclease ERCC1/XPF in living
cells. Science 1999, 284:958-961.
39. Kruhlak MJ, Lever MA, Fischle W, Verdin E, Bazett-Jones DP, Hendzel MJ:
Reduced mobility of the alternate splicing factor (ASF) through the
nucleoplasm and steady state speckle compartments. J Cell Biol 2000,
150:41-51.
40. Phair RD, Misteli T: High mobility of proteins in the mammalian cell
nucleus. Nature 2000, 404:604-609.
41. Bartova E, Pachernik J, Harnicarova A, Kovarik A, Kovarikova M,
Hofmanova J, Skalnikova M, Kozubek M, Kozubek S: Nuclear levels and
patterns of histone H3 modification and HP1 proteins after inhibition of
histone deacetylases. J Cell Sci 2005, 118:5035-5046.
42. Taddei A, Maison C, Roche D, Almouzni G: Reversible disruption of
pericentric heterochromatin and centromere function by inhibiting
deacetylases. Nat Cell Biol 2001, 3:114-120.
43. Ayoub N, Jeyasekharan AD, Bernal JA, Venkitaraman AR: HP1-beta
mobilization promotes chromatin changes that initiate the DNA damage
response. Nature 2008, 453:682-686.
44. Ayoub N, Jeyasekharan AD, Venkitaraman AR: Mobilization and
recruitment of HP1: a bimodal response to DNA breakage. Cell Cycle
2009, 8:2945-2950.
45. Melcer S, Meshorer E: Chromatin plasticity in pluripotent cells. Essays
Biochem 2010, 48:245-262.
46. Meaburn KJ, Misteli T: Locus-specific and activity-independent gene
repositioning during early tumorigenesis. J Cell Biol 2008, 180:39-50.
47. Bartova E, Krejci J, Harnicarova A, Kozubek S: Differentiation of human
embryonic stem cells induces condensation of chromosome territories
and formation of heterochromatin protein 1 foci. Differentiation 2008,
76:24-32.
48. Kupper K, Kolbl A, Biener D, Dittrich S, von Hase J, Thormeyer T, Fiegler H,
Carter NP, Speicher MR, Cremer T, Cremer M: Radial chromatin positioning
is shaped by local gene density, not by gene expression. Chromosoma
2007, 116:285-306.
49. Muratani M, Gerlich D, Janicki SM, Gebhard M, Eils R, Spector DL:
Metabolic-energy-dependent movement of PML bodies within the
mammalian cell nucleus. Nat Cell Biol 2002, 4:106-110.
50. Guan Y, Xu M, Liang Z, Xu N, Lu Z, Han Q, Zhang Y, Zhao XS:
Heterogeneous transportation of alpha1B-adrenoceptor in living cells.
Biophys Chem 2007, 127:149-154.
51. Odenheimer J, Heermann DW, Kreth G: Brownian dynamics simulations
reveal regulatory properties of higher-order chromatin structures. Eur
Biophys J 2009, 38:749-756.
52. Bartova E, Pachernik J, Kozubik A, Kozubek S: Differentiation-specific
association of HP1alpha and HP1beta with chromocentres is correlated
with clustering of TIF1beta at these sites. Histochem Cell Biol 2007,
127:375-388.
53. Nguyen VT, Giannoni F, Dubois MF, Seo SJ, Vigneron M, Kedinger C,
Bensaude O: In vivo degradation of RNA polymerase II largest subunit
triggered by alpha-amanitin. Nucleic Acids Res 1996, 24:2924-2929.
54. Matula P, Kozubek M, Dvorak V: Fast point-based 3-D alignment of live
cells. IEEE Trans Image Process 2006, 15:2388-2396.
55. Uhlírová R, Horáková AH, Galiová G, Legartová S, Matula P, Fojtová M,
Varecha M, Amrichová J, Vondrácek J, Kozubek S, Bártová E: SUV39h- and
A-type lamin-dependent telomere nuclear rearrangement. J Cell Biochem
2010, 109:915-926.
56. Zack GW, Rogers WE, Latt SA: Automatic measurement of sister
chromatid exchange frequency. J Histochem Cytochem 1977, 25:741-753.
57. Michalet X: Mean square displacement analysis of single-particle
trajectories with localization error: Brownian motion in an isotropic
medium. Phys Rev E Stat Nonlin Soft Matter Phys 2011, 82:041914.
doi:10.1186/1756-8935-4-5
Cite this article as: Stixová et al.: Heterogeneity in the kinetics of
nuclear proteins and trajectories of substructures associated with
heterochromatin. Epigenetics & Chromatin 2011 4:5.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Stixová et al. Epigenetics & Chromatin 2011, 4:5
http://www.epigeneticsandchromatin.com/content/4/1/5
Page 17 of 17